| Product Code: ETC9971638 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Non-invasive Prenatal Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Non-invasive Prenatal Testing Market - Industry Life Cycle |
3.4 United States (US) Non-invasive Prenatal Testing Market - Porter's Five Forces |
3.5 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.7 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.9 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 United States (US) Non-invasive Prenatal Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of non-invasive prenatal testing (NIPT) as a safer alternative to invasive procedures. |
4.2.2 Technological advancements leading to more accurate and reliable NIPT results. |
4.2.3 Growing demand for early detection of genetic disorders and chromosomal abnormalities in fetuses. |
4.3 Market Restraints |
4.3.1 High cost associated with NIPT tests limiting accessibility for some population segments. |
4.3.2 Concerns regarding the ethical implications of genetic testing and potential discrimination based on test results. |
4.3.3 Limited insurance coverage for NIPT tests, leading to out-of-pocket expenses for patients. |
5 United States (US) Non-invasive Prenatal Testing Market Trends |
6 United States (US) Non-invasive Prenatal Testing Market, By Types |
6.1 United States (US) Non-invasive Prenatal Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Products, 2021- 2031F |
6.1.4 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Assay Kits and Reagents, 2021- 2031F |
6.1.6 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Disposables, 2021- 2031F |
6.1.7 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.8 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By NGS Systems, 2021- 2031F |
6.1.9 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Non-invasive Prenatal Testing Market, By Method |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Ultrasound Detection, 2021- 2031F |
6.2.4 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Biochemical Screening Tests, 2021- 2031F |
6.2.6 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Cell-free DNA in Maternal Plasma Tests, 2021- 2031F |
6.3 United States (US) Non-invasive Prenatal Testing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Trisomy, 2021- 2031F |
6.3.3 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Microdeletion Syndrome, 2021- 2031F |
6.3.4 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.4 United States (US) Non-invasive Prenatal Testing Market, By Test Type |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Materni21, 2021- 2031F |
6.4.3 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Harmony, 2021- 2031F |
6.4.4 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Panorama, 2021- 2031F |
6.4.5 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Verify, 2021- 2031F |
6.4.6 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By NIFTY, 2021- 2031F |
6.4.7 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Non-invasive Prenatal Testing Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By NGS, 2021- 2031F |
6.5.3 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By WGS, 2021- 2031F |
6.5.4 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Non-invasive Prenatal Testing Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.6.3 United States (US) Non-invasive Prenatal Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
7 United States (US) Non-invasive Prenatal Testing Market Import-Export Trade Statistics |
7.1 United States (US) Non-invasive Prenatal Testing Market Export to Major Countries |
7.2 United States (US) Non-invasive Prenatal Testing Market Imports from Major Countries |
8 United States (US) Non-invasive Prenatal Testing Market Key Performance Indicators |
8.1 Average turnaround time for NIPT results. |
8.2 Adoption rate of NIPT among healthcare providers. |
8.3 Number of research studies and publications supporting the effectiveness of NIPT. |
8.4 Rate of reimbursement for NIPT tests by insurance providers. |
8.5 Patient satisfaction scores related to the NIPT testing process and counseling services. |
9 United States (US) Non-invasive Prenatal Testing Market - Opportunity Assessment |
9.1 United States (US) Non-invasive Prenatal Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Non-invasive Prenatal Testing Market Opportunity Assessment, By Method, 2021 & 2031F |
9.3 United States (US) Non-invasive Prenatal Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) Non-invasive Prenatal Testing Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.5 United States (US) Non-invasive Prenatal Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.6 United States (US) Non-invasive Prenatal Testing Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 United States (US) Non-invasive Prenatal Testing Market - Competitive Landscape |
10.1 United States (US) Non-invasive Prenatal Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Non-invasive Prenatal Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here